Researchers tested honokiol, magnolol, and three mixture ratios in SH-SY5Y neuronal cells exposed to amyloid-β or MPP+-induced toxicity. Individual compounds at 0.1 μM and mixtures at 0.0001 μM significantly reduced intracellular reactive oxygen species. The mixtures showed synergistic effects in this model, but no animal or patient evidence is yet available.
Key findings
- Honokiol and magnolol at 0.1 μM and all three mixtures at 0.0001 μM significantly reduced intracellular ROS versus Aβ-treated cells (p
Why this matters globally
Neurodegenerative diseases impose a global burden and need new targets. This work prioritizes a hypothesis that combining Magnolia-derived compounds may reduce oxidative stress at very low concentrations, but translation from cultured cells to medicines has a high failure rate and requires many stages.
Thai researcher contribution
The Srinakharinwirot University pharmacy team integrated pharmacognosy, pharmaceutical chemistry, cell assays, and computational analysis to screen natural-compound mechanisms systematically.
Limitations to consider
Only one human neuroblastoma cell line and acute-toxicity models were used. Lower ROS does not establish neuronal survival or restored brain function. Predicted ADMET is not measured pharmacokinetics; absorption, blood–brain-barrier penetration, safe dosing, interactions, and animal or human effects remain unknown. The findings do not support self-treatment or supplement use.
Verify the original sources
International Journal of Molecular SciencesRead the original article↗DOI: 10.3390/ijms27146096